LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.

Source:http://linkedlifedata.com/resource/pubmed/id/20724988

Download in:

View as

General Info

PMID
20724988